Recognizing risk factors associated with poor outcomes among patients with COVID-19

P Rodriguez-Miguelez, A Heefner… - Progress in cardiovascular …, 2023 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic has affected> 610 million
people globally, exerting major social, economic, and health impacts. Despite the large …

Forensic and Pharmaceutical Risks in the Organization of Pharmacotherapy of Covid, Post-Covid and Long-Covid Disorders. COVID-19 and Vaccination Practice …

V Shapovalova - SSP Modern Pharmacy and Medicine, 2022 - ssp.ee
The COVID-19 pandemic has strained the healthcare system. It is important to consider
forensic and pharmaceutical risks in the organization of vaccination practices and …

Potential of Black Seeds (Nigella sativa) in the Management of Long COVID or Post-acute Sequelae of COVID-19 (PASC) and Persistent COVID-19 Symptoms–An …

NM Pakkir Maideen, A Hassan Jumale… - … Current Drug Targets …, 2023 - ingentaconnect.com
Background: Some individuals may experience symptoms persisting for many months after
the recovery from COVID-19 and patients with Long COVID are managed mainly with …

Risk factors for severe COVID-19 among patients with systemic lupus erythematosus: a real-world analysis of a large representative US administrative claims …

C Calabrese, G Atefi, KA Evans, M Moynihan… - RMD open, 2023 - rmdopen.bmj.com
Objectives To identify risk factors for progression to severe COVID-19 and estimate the odds
of severe COVID-19 associated with vaccination among patients with systemic lupus …

Outcomes and characteristics of patients hospitalized for COVID-19 in British Columbia, Ontario and Quebec during the Omicron wave

T Lee, MP Cheng, DC Vinh, TC Lee, KC Tran… - … Open Access Journal, 2023 - cmajopen.ca
Background: Omicron is the current predominant variant of concern of SARS-CoV-2. We
hypothesized that vaccination alters outcomes of patients hospitalized with COVID-19 during …

Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory …

C Ferreras, C Hernández-Blanco, A Martín-Quirós… - Cytotherapy, 2024 - Elsevier
Background aims There are currently no effective anti-viral treatments for coronavirus
disease 2019 (COVID-19)–hospitalized patients with hypoxemia. Lymphopenia is a …

[HTML][HTML] Association Between the 10-Year ASCVD Risk Score and COVID-19 Complications Among Healthy Adults (Analysis from the National Cohort COVID …

R Khatib, N Glowacki, JC Lauffenburger… - The American journal of …, 2023 - Elsevier
COVID-19 complications have been linked to worse outcomes among patients with
established atherosclerotic cardiovascular disease (ASCVD). Less is known about the …

Persistent short nighttime sleep duration is associated with a greater post-COVID risk in fully mRNA-vaccinated individuals

P Xue, I Merikanto, F Chung, CM Morin, C Espie… - Translational …, 2023 - nature.com
Short nighttime sleep duration impairs the immune response to virus vaccination, and long
nighttime sleep duration is associated with poor health status. Thus, we hypothesized that …

[HTML][HTML] Vaccine-Induced or Hybrid Immunity and COVID-19-Associated Mortality During the Omicron Wave: A Retrospective Observational Study in the Elderly

M Weigert, A Beyerlein, K Katz, R Schulte… - Deutsches Ärzteblatt …, 2023 - ncbi.nlm.nih.gov
Background It is not yet entirely clear to what extent vaccine-induced or hybrid immunity
offers protection from death during the omicron wave of the COVID-19 pandemic in …

Determinants of risk factors for COVID-19 transmission in densely populated areas: Insights from the first wave of the pandemic

I Nurlinawati, M Sumiarsih, P Andarwati, L Andayasari… - 2023 - opal.latrobe.edu.au
Introduction: COVID-19 spreads quickly, especially in densely populated countries like
Indonesia. Understanding transmission factors can support in reducing transmission rates …